Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PA) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Global Medical REIT (GMRE-PA) over the last 14 years, with Q3 2025 value amounting to -$5.1 million.

  • Global Medical REIT's Profit After Tax fell 24915.95% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $643000.0, marking a year-over-year decrease of 8506.04%. This contributed to the annual value of $6.7 million for FY2024, which is 6920.95% down from last year.
  • Global Medical REIT's Profit After Tax amounted to -$5.1 million in Q3 2025, which was down 24915.95% from $585000.0 recorded in Q2 2025.
  • Global Medical REIT's 5-year Profit After Tax high stood at $14.2 million for Q2 2023, and its period low was -$5.1 million during Q3 2025.
  • For the 5-year period, Global Medical REIT's Profit After Tax averaged around $3.4 million, with its median value being $3.4 million (2024).
  • In the last 5 years, Global Medical REIT's Profit After Tax skyrocketed by 26977.05% in 2023 and then plummeted by 24915.95% in 2025.
  • Global Medical REIT's Profit After Tax (Quarter) stood at $5.5 million in 2021, then crashed by 66.32% to $1.8 million in 2022, then plummeted by 70.18% to $551000.0 in 2023, then skyrocketed by 150.27% to $1.4 million in 2024, then tumbled by 466.79% to -$5.1 million in 2025.
  • Its Profit After Tax was -$5.1 million in Q3 2025, compared to $585000.0 in Q2 2025 and $3.7 million in Q1 2025.